Clarissa Desjardins, Ph.D.

Clarissa Desjardins, Ph.D.

DirectoratINSMED· In proxies 2023–2025

Clarissa Desjardins, Ph.D. sits on 6 public boards.

Boards1

  • INSMEDDirector · 4 yr on the boardIndependentScience and Technology (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. INSMEDPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +410%
  2. None Recent Public Board Service: Director until June 2023, BELLUS Health Inc. (Nasdaq: BLUPublic company
    • Director? – PresentNo stock prices for these years
  3. TSX: BLU) Director until June 2021, Xenon Pharmaceuticals (Nasdaq: XENE)Public company
    • Director? – PresentNo stock prices for these years
  4. BELLUS Health Inc.Public company
    • Director? – 2023No stock prices for these years
  5. Xenon PharmaceuticalsPublic company
    • Director? – 2021No stock prices for these years
  6. Director Caprion Pharmaceuticals Inc.Public company · 9 yr
    • Director1998 – 2007 · 9 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?